NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=128310&wire=1 or contact Joseph E. Levi, Esq.

Artificial intelligence (AI) continues to garner lots of attention. And for good reason.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Walgreens Boots Alliance, Inc. (NASDAQ:WBA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=128309&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, Feb. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Cassava Sciences, Inc. (NASDAQ: SAVA) between February 7, 2024 and November 24, 2024, both dates inclusive (the “Class Period”), of the important February 10, 2025 lead plaintiff deadline.

NEW YORK, Feb. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) between April 2, 2020 and January 16, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2025.

Historically, few companies have demonstrated more millionaire-maker potential than Nvidia (NVDA 0.90%). The tech giant's shares have soared by more than 22,000% over the last decade, generating plenty of shareholder wealth in the process.

Roughly one month into 2025, the stock market is off to a decent but far from spectacular start. As of this writing, the S&P 500, the Nasdaq Composite, and the Dow Jones Industrial Average are up 3.2%, 2%, and 5.6%, respectively.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Electronic Arts Inc. ("Electronic Arts Inc.") (NASDAQ:EA) concerning possible violations of federal securities laws. On January 22, 2025, EA issued a press release pre-announcing their preliminary Q3 FY25 results and announcing a guide-down from the company's prior expectations.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period"), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Transocean Ltd. (NYSE:RIG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/transocean-ltd-lawsuit-submission-form?prid=128306&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Napco Security Technologies, Inc. ("Napco Security Technologies, Inc.") (NASDAQ:NSSC) concerning possible violations of federal securities laws. On February 3, 2025, news website Investing.com published an article entitled "NAPCO Security stock tumbles after Q2 sales decline.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Transocean Ltd. (NYSE:RIG) between October 31, 2023 and September 2, 2024, both dates inclusive (the "Class Period"), of the important February 24, 2025 lead plaintiff deadline.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Electronic Arts Inc. (NASDAQ: EA) resulting from allegations that EA may have issued materially misleading business information to the investing public. SO WHAT: If you purchased EA securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=128303&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128304&wire=1 or contact Joseph E. Levi, Esq.

SYDNEY, Australia and AUCKLAND, New Zealand, Feb. 10, 2025 (GLOBE NEWSWIRE) -- EXL [NASDAQ: EXLS], a global data and AI company, is hosting AI in Action: Australia & New Zealand 2025, a virtual event designed to equip businesses with practical strategies and cutting-edge innovations to harness and scale AI for measurable impact. The highly anticipated event is scheduled for 20th March 2025 at 12pm AEDT.

Universal Health Services (UHS) remains a BUY due to stable long-term fundamentals, consistent revenue growth, and improving margins. UHS's strong financial performance, including a 45% increase in adjusted diluted EPS and improved EBITDA margins, underscores its resilience and efficiency. With COVID disruptions over, UHS is poised for 6%-7% long-term growth, supported by robust performance in both acute and behavioral health segments.

HQH offers a high dividend yield of 13.6%, making it attractive for income-focused investors, despite potential tax consequences. The fund trades at a 7.86% discount to NAV, presenting a good entry point, especially with anticipated interest rate cuts and increased healthcare spending. HQH's portfolio is heavily concentrated in Biotechnology (64.6%), posing sector-specific risks but also benefiting from projected growth in biotech and healthcare spending.

NEW YORK, NY / ACCESS Newswire / February 9, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE: GSK) between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.

NEW YORK, Feb. 09, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Target Corporation (NYSE: TGT) between August 26, 2022 and November 19, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 1, 2025.